Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States
- 1 May 1998
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 12 (7), 785-793
- https://doi.org/10.1097/00002030-199807000-00015
Abstract
To determine the willingness of populations at high risk of HIV-1 infection to participate in HIV vaccine efficacy trials, determine factors influencing decision-making, and evaluate knowledge levels of vaccine trial concepts.Keywords
This publication has 9 references indexed in Scilit:
- Willingness to Participate in HIV-1 Vaccine Efficacy Trials and the Effect of Media Events Among Gay and Bisexual Men in New York CityJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Feasibility of Human Immunodeficiency Virus Vaccine Trials in Homosexual Men in the United States: Risk Behavior, Seroincidence, and Willingness to ParticipateThe Journal of Infectious Diseases, 1996
- The feasibility of HIV-1 vaccine efficacy trials among gay/bisexual men in New York City: Project ACHIEVEAIDS, 1996
- HIV vaccines: where we are and where we are goingThe Lancet, 1996
- Interest among Gay/Bisexual Men in Greater Boston in Participating in Clinical Trials of Preventive HIV VaccinesJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Weight Loss Associated with HIV Seroconversion Among Injection-Drug UsersJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Candidate AIDS VaccinesNew England Journal of Medicine, 1995
- Preventing Discrimination against Volunteers in Preventive HIV Vaccine Efficacy Trials: Conference SummaryAIDS Research and Human Retroviruses, 1995
- HIV vaccine trials: will intravenous drug users enroll?American Journal of Public Health, 1994